Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,330
datasets available to search
ShareScore release 0.9.0
Dataset results
4,330 results for “Melanoma”
Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma
ClinicalTrials.gov study NCT00788775. IPD Sharing: NO. Countries: 1. Publications: 1.
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
ClinicalTrials.gov study NCT01274338. IPD Sharing: Not stated. Countries: 2. Publications: 3.
High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
ClinicalTrials.gov study NCT02203604. IPD Sharing: NO. Countries: 1. Publications: 1.
SciBase International Melanoma Pivotal Study
ClinicalTrials.gov study NCT01077050. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Phase II Study of UCN-01 in Metastatic Melanoma
ClinicalTrials.gov study NCT00072189. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma
ClinicalTrials.gov study NCT00110994. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma
ClinicalTrials.gov study NCT00314106. IPD Sharing: Not stated. Countries: 1. Publications: 2.
LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma
ClinicalTrials.gov study NCT01010984. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma
ClinicalTrials.gov study NCT01227889. IPD Sharing: Not stated. Countries: 12. Publications: 6.
A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain
ClinicalTrials.gov study NCT01266967. IPD Sharing: Not stated. Countries: 6. Publications: 3.
Relative Bioavailability Study of Subcutaneous Injection Versus Intravenous Infusion of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-555/KEYNOTE-555)
ClinicalTrials.gov study NCT03665597. IPD Sharing: YES. Countries: 4. Publications: 1.
A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma
ClinicalTrials.gov study NCT01001299. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study
ClinicalTrials.gov study NCT00462423. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma
ClinicalTrials.gov study NCT04123470. IPD Sharing: NO. Countries: 2. Publications: 0.
Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma
ClinicalTrials.gov study NCT00612222. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain
ClinicalTrials.gov study NCT02039947. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Trial of pIL-12/MK-3475 in Metastatic Melanoma
ClinicalTrials.gov study NCT02493361. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Vemurafenib in Participants With Metastatic Melanoma
ClinicalTrials.gov study NCT01307397. IPD Sharing: Not stated. Countries: 44. Publications: 2.
Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye
ClinicalTrials.gov study NCT00329641. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients
ClinicalTrials.gov study NCT00525031. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.